Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 08, 2019

SELL
$217.44 - $243.88 $619,704 - $695,058
-2,850 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$219.29 - $241.72 $2.8 Million - $3.09 Million
-12,771 Reduced 81.76%
2,850 $667,000
Q1 2019

May 10, 2019

SELL
$216.71 - $338.96 $344,135 - $538,268
-1,588 Reduced 9.23%
15,621 $3.69 Million
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $355,087 - $449,756
-1,275 Reduced 6.9%
17,209 $5.18 Million
Q3 2018

Nov 26, 2018

BUY
$293.51 - $383.83 $252,418 - $330,093
860 Added 4.88%
18,484 $6.53 Million
Q2 2018

Aug 09, 2018

BUY
$257.52 - $306.91 $792,389 - $944,362
3,077 Added 21.15%
17,624 $5.12 Million
Q1 2018

Jul 26, 2018

BUY
$260.13 - $367.91 $2.75 Million - $3.89 Million
10,564 Added 265.23%
14,547 $3.98 Million
Q1 2018

May 03, 2018

SELL
$260.13 - $367.91 $1.76 Million - $2.49 Million
-6,767 Reduced 62.95%
3,983 $14.5 Million
Q4 2017

Feb 06, 2018

BUY
$307.64 - $344.58 $1.87 Million - $2.09 Million
6,075 Added 129.95%
10,750 $0
Q3 2017

Nov 09, 2017

BUY
$281.15 - $329.69 $1.03 Million - $1.2 Million
3,646 Added 354.32%
4,675 $1.46 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,029
1,029 $279,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.